drugset / Trial / NCT00777023

Study of Gabapentin Extended Release (G-ER)in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in Postmenopausal Women.

NCT00777023

Phase 3 Completed 565 enrolled Depomed
RandomizedFactorialTriple-blindTreatment

Summary

Depomed's Gabapentin Extended Release is an investigational, extended release formulation of gabapentin that is being studied for the treatment of hot flashes in postmenopausal women

Timeline

Start
2008-10
Primary completion
2009-07
Completion
2009-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule 1200 mg
Subject Gabapentin Small molecule 1800 mg

Indications

No indication recorded.